Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 2 of 2 for:    VU319

Multiple Ascending Dose Putative Cognitive Enhancer VU319

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04051801
Recruitment Status : Withdrawn (Further development has been outlicensed to Acadia Pharmaceuticals)
First Posted : August 9, 2019
Last Update Posted : May 28, 2021
Sponsor:
Information provided by (Responsible Party):
Paul Newhouse, Vanderbilt University Medical Center

No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
Recruitment Status : Withdrawn
Actual Primary Completion Date : May 25, 2021
Actual Study Completion Date : May 25, 2021